Recent Analyst Forecasts and Stock Ratings
CRISPR Therapeutics AG FAQ's
CRISPR Therapeutics AG has been rated by research analysts at Morgan Stanley, Chardan Capital, Needham, Evercore ISI, RBC Capital, Wells Fargo in the past 90 days.
CRISPR Therapeutics AG has been rated by research analysts at Morgan Stanley, Chardan Capital, Needham, Evercore ISI, RBC Capital, Wells Fargo in the past 90 days.